Slide background

The C3P3 company for synthetic gene therapy and bioproduction

Eukarÿs is the first company to successfully developing an artificial expression system for the eukaryotes, which opens up novels avenues for synthetic gene therapy – a radically novel and effective therapeutic approach for the treatment of human disorders – as well a broad range of non-therapeutic applications.